Back to dashboard
CommercialCoverageMedium impact

Laparoscopic, Percutaneous, and Transcervical Techniques for Uterine Fibroid Myolysis

Blue Cross & Blue Shield of Mississippi·MS · OB-GYN·Medical Policy
Effective date
Not stated
We identified it
Jun 20, 2026
Days to comply
—

Summary

BCBS MS has established a new medical policy defining coverage criteria for radiofrequency ablation treatments for uterine fibroids. The policy covers specific RFA systems (Acessa for laparoscopic and Sonata for transcervical approaches) when strict clinical criteria are met, while declaring other myolysis techniques investigational.

Action Required

Action needed
Immediately: OB-GYN billing staff must review current uterine fibroid treatment authorizations against new BCBS MS policy A.4.01.19. Ensure all RFA procedures meet size criteria (fibroids <10cm for Acessa laparoscopic, <7cm for Sonata transcervical) and document medical necessity including symptoms and uterine-sparing preference. Flag any laser, bipolar, cryomyolysis, or MRI-guided ablation procedures as investigational and requiring special review.

Related policy hubs